Literature DB >> 19970599

Multiple skin tumors in mice following a single painting with 9:10 dimethyl-1:2 benzanthracene.

L W Law.   

Abstract

Entities:  

Year:  1941        PMID: 19970599      PMCID: PMC1965298     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  1 in total

1.  Skin tumors following a single application of methylcholanthrene in C57 brown mice.

Authors:  G B Mider; J J Morton
Journal:  Am J Pathol       Date:  1939-05       Impact factor: 4.307

  1 in total
  5 in total

1.  The influence of preliminary irritation by acetic acid or croton oil on skin tumour production in mice after a single application of dimethyl-benzathracene, benzopyrene, or dibenzanthracene.

Authors:  A W Pound
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

2.  THE INITIATING AND PROMOTING ELEMENTS IN TUMOR PRODUCTION : AN ANALYSIS OF THE EFFECTS OF TAR, BENZPYRENE, AND METHYLCHOLANTHRENE ON RABBIT SKIN.

Authors:  W F Friedewald; P Rous
Journal:  J Exp Med       Date:  1944-08-01       Impact factor: 14.307

3.  The development of malignant tumours of mouse skin after initiating and promoting stimuli. I. The effect of a single application of 9, 10-dimethyl-1, 2-benzanthracene (DMBA), with and without subsequent treatment with croton oil.

Authors:  F J ROE
Journal:  Br J Cancer       Date:  1956-03       Impact factor: 7.640

4.  The development of malignant tumours of mouse skin after initiating and promoting stimuli. IV. Comparison of the effects of single and divided initiating doses of 9, 10-dimethyl-1, 2-benzanthracene (DMBA).

Authors:  M H SALAMAN; F J ROE
Journal:  Br J Cancer       Date:  1956-03       Impact factor: 7.640

5.  The influence of carcinogenic dosage and of sex on the induction of epitheliomas and sarcomas in the dorsal skin of rats.

Authors:  C P Cherry; A Glucksmann
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.